Bottom line
Is DVSMX a good fund? The bottom line
DVSMX is the Investor Share Class share class of Driehaus Small Cap Growth Fund, a managed small-cap mutual fund from Driehaus Mutual.
Annual fees run 0.93% — about $93 a year on every $10,000 invested, cheaper than 58% of small-cap funds we track.
It returned +16.7% over one year, +7.1% a year over five years, +17.1% a year over ten (as of Dec 31, 2025, per its prospectus).
With $1.6 billion in net assets and 122 holdings, its largest position is Northern Institutional Funds (2.7%) and the top 10 make up 18.9% of the portfolio.
What stands out
- No front-end sales load
What to watch
- High turnover (152% a year) can mean more taxable distributions
Updated Nov 19, 2026
What DVSMX invests in
Driehaus Small Cap Growth Fund seeks to maximize capital appreciation.
The Fund uses a growth style of investment in equity securities, including common stocks and other equity securities of issuers. Under normal market conditions, the Fund invests at least 80% of its net assets (plus the amount of borrowings for investment purposes) in the equity securities of U.S. small-capitalization (small-cap) companies. For purposes of the Fund, the investment adviser considers a company to be a small cap company if it is within the same market capitalization range at the time of investment as those included in the Russell 2000 Growth Index. For the avoidance of doubt, while the reference index is float-adjusted, meaning it excludes closely held and other shares unavailable to investors, the investment adviser does not consider a float-adjustment when determining the market capitalization of a company. As of March 31, 2026, approximately 86% of the Russell 2000…
From the fund's prospectus (filed Apr 29, 2026).
DVSMX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| DVSMX | +16.7% | +7.1% | +17.1% |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What DVSMX costs
On a $10,000 investment, DVSMX's 0.93% expense ratio costs about $93 a year. The prospectus estimates $1,143 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
DVSMX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Northern Institutional Funds | 2.71% |
| 2 | Vicor Corp VICR | 2.03% |
| 3 | Guardant Health Inc GH | 1.99% |
| 4 | Silicon Motion Technology Corp SIMO | 1.98% |
| 5 | Apogee Therapeutics Inc APGE | 1.81% |
| 6 | Praxis Precision Medicines Inc PRAX | 1.75% |
| 7 | Definium Therapeutics Inc DFTX | 1.74% |
| 8 | Planet Labs Pbc PL | 1.73% |
| 9 | Spyre Therapeutics Inc SYRE | 1.70% |
| 10 | Curtiss-wright Corp CW | 1.49% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 18.9% of the fund. See all top 25 holdings and asset mix →